|
1
|
Oldenburg WA, Lau LL, Rodenberg TJ,
Edmonds HJ and Burger CD: Acute mesentericischemia: a clinical
review. Arch Intern Med. 164:1054–1062. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berlanga J, Prats P, Remirez D, Gonzalez
R, Lopez-Saura P, et al: Prophylactic use of epidermal growth
factor reduces ischemia/reperfusion intestinal damage. Am J Pathol.
161:373–379. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tendler DA: Acute intestinal ischemia and
infarction. Semin Gastrointest Dis. 14:66–76. 2003.PubMed/NCBI
|
|
4
|
Zhang M and Carroll MC: Natural antibody
mediated innate autoimmune response. Mol Immunol. 44:103–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leaphart CL and Tepas JJ III: The gut is a
motor of organ system dysfunction. Surgery. 141:563–569. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rotstein OD: Pathogenesis of multiple
organ dysfunction syndrome: gut origin, protection, and
decontamination. Surg Infect (Larchmt). 1:217–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsang CK, Qi H, Liu LF and Zheng XF:
Targeting mammalian target of rapamycin (mTOR) for health and
diseases. Drug Discov Today. 12:112–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weichhart T: Mammalian target of
rapamycin: a signaling kinase for every aspect of cellular life.
Methods Mol Biol. 821:1–14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Q and Guan KL: Expanding mTOR
signaling. Cell Res. 17:666–681. 2012. View Article : Google Scholar
|
|
10
|
Zoncu R, Efeyan A and Sabatini DM: mTOR:
from growth signal integration to cancer, diabetes and ageing. Nat
Rev Mol Cell Biol. 12:21–35. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hay N and Sonenberg N: Upstream and
downstream of mTOR. Genes Dev. 18:1926–1945. 2004. View Article : Google Scholar
|
|
12
|
Koh PO: Melatonin prevents ischemic brain
injury through activation of the mTOR/p70S6 kinase signaling
pathway. Neurosci Lett. 444:74–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koh PO: Ginkgo biloba extract (EGb
761) prevents cerebral ischemia-induced p70S6 kinase and S6
phosphorylation. Am J Chin Med. 38:727–734. 2010. View Article : Google Scholar
|
|
14
|
Shi GD, OuYang YP, Shi JG, Liu Y, Yuan W
and Jia LS: PTEN deletion prevents ischemic brain injury by
activating the mTOR signaling pathway. Biochem Biophys Res Commun.
404:941–945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vigneron F, Dos Santos P, Lemoine S,
Bonnet M, Tariosse L, Couffinhal T, Duplaà C and Jaspard-Vinassa B:
GSK-3β at the crossroads in the signalling of heart
preconditioning: implication of mTOR and Wnt pathways. Cardiovasc
Res. 90:49–56. 2011.
|
|
16
|
Kojima M, Hosoda H, Date Y, Nakazato M,
Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing
acylated peptide from stomach. Nature. 402:656–660. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arvat E, Di Vito L, Broglio F, Papotti M,
Muccioli G, et al: Preliminary evidence that Ghrelin, the natural
GH secretagogue (GHS)-receptor ligand, strongly stimulates GH
secretion in humans. J Endocrinol Invest. 23:493–495. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu JT and Kral JG: Ghrelin: integrative
neuroendocrine peptide in health and disease. Ann Surg.
239:464–474. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cowley MA and Grove KL: Ghrelin -
satisfying a hunger for the mechanism. Endocrinology.
145:2604–2606. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dixit VD, Schaffer EM, Pyle RS, Collins
GD, Sakthivel SK, Palaniappan R, Lillard JW Jr and Taub DD: Ghrelin
inhibits leptin- and activation-induced pro-inflammatory cytokine
expression by human monocytes and T cells. J Clin Invest.
114:57–66. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li WG, Gavrila D, Liu X, Wang L,
Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C and
Weintraub NL: Ghrelin inhibits pro-inflammatory responses and
nuclear factor-kappaB activation in human endothelial cells.
Circulation. 109:2221–2226. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Konturek PC, Brzozowski T, Walter B,
Burnat G, Hess T, Hahn EG and Konturek SJ: Ghrelin-induced
gastroprotection against ischemia-reperfusion injury involves an
activation of sensory afferent nerves and hyperemia mediated by
nitric oxide. Eur J Pharmacol. 536:171–181. 2006. View Article : Google Scholar
|
|
23
|
Brzozowski T, Konturek PC, Sliwowski Z,
Pajdo R, Drozdowicz D, Kwiecien S, Burnat G, Konturek S and Pawlik
WW: Prostaglandin/cyclooxygenase pathway in ghrelin-induced
gastroprotection against ischemia-reperfusion injury. J Pharmacol
Exp Ther. 319:477–487. 2006. View Article : Google Scholar
|
|
24
|
Brzozowski T, Konturek PC, Sliwowski Z,
Drozdowicz D, Kwiecien S, Pawlik M, Pajdo R, Konturek SJ, Pawlik WW
and Hahn EG: Neural aspects of ghrelin-induced gastroprotection
against mucosal injury induced by noxious agents. J Physiol
Pharmacol. 57(Suppl 6): S63–S76. 2006.PubMed/NCBI
|
|
25
|
Pawlik MW, Obuchowicz R, Biernat J,
Szczepanski W, Pajdo R, Kwiecień S, Brzozowski T, Konturek SJ and
Pawlik WW: Effects of peripherally and centrally applied ghrelin in
the pathogenesis of ischemia-reperfusion induced injury of the
small intestine. J Physiol Pharmacol. 62:429–439. 2011.PubMed/NCBI
|
|
26
|
Wu R, Dong W, Ji Y, Zhou M, Marini CP,
Ravikumar TS and Wang P: Orexigenic hormone ghrelin attenuates
local and remote organ injury after intestinal
ischemia-reperfusion. PLoS One. 3:e20262008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weichhart T, Costantino G, Poglitsch M,
Rosner M, Zeyda M, et al: The TSC-mTOR signaling pathway regulates
the innate inflammatory response. Immunity. 29:565–577. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chiu CJ, McArdle AH, Brown R, Scott HJ and
Gurd FN: Intestinal mucosal lesion in low-flow states. I A
morphological, hemodynamic, and metabolic reappraisal. Arch Surg.
101:478–483. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bachofen M and Weibel ER: Structural
alterations of lung parenchyma in the adult respiratory distress
syndrome. Clin Chest Med. 3:35–56. 1982.PubMed/NCBI
|
|
30
|
Collard CD and Gelman S: Pathophysiology,
clinical manifestations, and prevention of ischemia-reperfusion
injury. Anesthesiology. 94:1133–1138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hattori N, Saito T, Yagyu T, Jiang BH,
Kitagawa K, et al: GH, GH receptor, GH secretagogue receptor, and
ghrelin expression in human T cells, B cells, and neutrophils. J
Clin Endocrinol Metab. 86:4284–4291. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Papotti M, Ghe C, Cassoni P, Catapano F,
Deghenghi R, et al: Growth hormone secretagogue binding sites in
peripheral human tissues. J Clin Endocrinol Metab. 85:3803–3807.
2000.PubMed/NCBI
|
|
33
|
Shuto Y, Shibasaki T, Wada K, Parhar I,
Kamegai J, et al: Generation of polyclonal antiserum against the
growth hormone secretagogue receptor (GHS-R): evidence that the
GHS-R exists in the hypothalamus, pituitary and stomach of rats.
Life Sci. 68:991–996. 2001. View Article : Google Scholar
|
|
34
|
Wu R, Dong W, Cui X, Zhou M, Simms HH, et
al: Ghrelin down-regulates pro-inflammatory cytokines in sepsis
through activation of the vagus nerve. Ann Surg. 245:480–486. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kojima M and Kangawa K: Ghrelin: structure
and function. Physiol Rev. 85:495–522. 2005. View Article : Google Scholar
|
|
36
|
Wang G, Lee HM, Englander E and Greeley GH
Jr: Ghrelin-not just another stomach hormone. Regul Pept.
105:75–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim DH and Sabatini DM: Raptor and mTOR:
subunits of a nutrient-sensitive complex. Curr Top Microbiol
Immunol. 279:259–270. 2004.PubMed/NCBI
|
|
38
|
Montagne J, Stewart MJ, Stocker H, Hafen
E, Kozma SC and Thomas G: Drosophila S6 kinase: a regulator
of cell size. Science. 285:2126–2119. 1999. View Article : Google Scholar
|
|
39
|
Shima H, Pende M, Chen Y, Fumagalli S,
Thomas G and Kozma SC: Disruption of the p70(s6k)/p85(s6k) gene
reveals a small mouse phenotype and a new functional S6 kinase.
EMBO J. 17:6649–6659. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lawrence JC Jr and Brunn GJ: Insulin
signaling and the control of PHAS-I phosphorylation. Prog Mol
Subcell Biol. 26:1–31. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Janelidze S, Hu BR, Siesjö P and Siesjö
BK: Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal
ischemia. Neurobiol Dis. 8:147–154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mengesdorf T, Proud CG, Mies G and Paschen
W: Mechanisms underlying suppression of protein synthesis induced
by transient focal cerebral ischemia in mouse brain. Exp Neurol.
177:538–546. 2002. View Article : Google Scholar
|
|
43
|
Koh PO, Cho JH, Won CK, Lee HJ, Sung JH
and Kim MO: Estradiol attenuates the focal cerebral ischemic injury
through mTOR/p70S6 kinase signaling pathway. Neurosci Lett.
436:62–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Weichhart T and Säemann MD: The multiple
facets of mTOR in immunity. Trends Immunol. 30:218–226. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Baker AK, Wang R, Mackman N and Luyendyk
JP: Rapamycin enhances LPS induction of tissue factor and tumor
necrosis factor-alpha expression in macrophages by reducing IL-10
expression. Mol Immunol. 46:2249–2255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Aoyagi T, Kusakari Y, Xiao CY, Inouye BT,
Takahashi M, Scherrer-Crosbie M, Rosenzweig A, Hara K and Matsui T:
Cardiac mTOR protects the heart against ischemia-reperfusion
injury. Am J Physiol Heart Circ Physiol. 303:H75–H85. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu R, Dong W, Zhou M, Zhang F, Marini CP,
Ravikumar TS and Wang P: Ghrelin attenuates sepsis-induced acute
lung injury and mortality in rats. Am J Respir Crit Care Med.
176:805–813. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sato N, Moore FA, Smith MA, Zou L,
Moore-Olufemi S, et al: Immune-enhancing enteral nutrients
differentially modulate the early pro-inflammatory transcription
factors mediating gut ischemia/reperfusion. J Trauma. 58:455–461.
2005. View Article : Google Scholar
|
|
49
|
dos Mendes SS, Candi A, Vansteenbrugge M,
Pignon MR, Bult H, Boudjeltia KZ, Munaut C and Raes M: Microarray
analyses of the effects of NF-kappaB or PI3K pathway inhibitors on
the LPS-induced gene expression profile in RAW264.7 cells:
synergistic effects of rapamycin on LPS-induced
MMP9-overexpression. Cell Signal. 21:1109–1122. 2009.PubMed/NCBI
|
|
50
|
Martins L, Fernández-Mallo D, Novelle MG,
Vázquez MJ, Tena-Sempere M, Nogueiras R, López M and Diéguez C:
Hypothalamic mTOR signaling mediates the orexigenic action of
ghrelin. PLoS One. 7:e469232012. View Article : Google Scholar : PubMed/NCBI
|
